Latest News
Landmark prostate cancer trial STAMPEDE finishes recruitment
After nearly 20 years of studying treatments for prostate cancer, the STAMPEDE clinical trial has finished recruiting new participants.
New podcast episode: How should we treat multi-drug resistant tuberculosis?
A new episode of trial talk has been released today covering the STREAM2 trial for World TB Day.
New methodology papers aim to improve clinical trials monitoring
Methodologists from the MRC Clinical Trials Unit at UCL have published two papers focusing on issues surrounding the monitoring of clinical trials.
Two-month regimen could dramatically cut length of tuberculosis treatment
A strategy of treating patients with a two-month, intensive antibiotic regimen, followed by close monitoring and re-treatment if required, was as effective at treating tuberculosis (TB) as the standard six-month regimen.